Profilo
Masayuki Kobayashi is Chairman at Taiho Oncology, Inc. since 2014, President & Representative Director at Taiho Pharmaceutical Co., Ltd. since 2012, and Director at Otsuka Holdings Co., Ltd. since 2017.
Formerly, Mr. Kobayashi was Chief Executive Officer at Otsuka America, Inc.
Posizioni attive di Masayuki Kobayashi
| Società | Posizione | Inizio |
|---|---|---|
| OTSUKA HOLDINGS CO., LTD. | Direttore/Membro del Consiglio | 30/03/2017 |
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops oncology drugs | Presidente | 03/04/2012 |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of orally administered anti-cancer agents for tumor types | Presidente | 01/04/2014 |
Precedenti posizioni note di Masayuki Kobayashi
| Società | Posizione | Fine |
|---|---|---|
Otsuka America, Inc.
Otsuka America, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures and sells pharmaceutical, nutraceutical products & consumer markets | Presidente | 31/03/2012 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Develops oncology drugs | Commercial Services |
Otsuka America, Inc.
Otsuka America, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures and sells pharmaceutical, nutraceutical products & consumer markets | Health Technology |
Otsuka Holdings Co., Ltd.
Otsuka Holdings Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in pharmaceutical preparations | Health Technology |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of orally administered anti-cancer agents for tumor types | Health Technology |
















